Skip to main content
  • 3109 Accesses

Abstract

Sickle cell disease (SCD) is a common genetic condition which impacts almost 30 million people worldwide. The hallmark of SCD is painful crises, with pain being the commonest cause for hospitalization. Understanding the pathophysiology of the disease and the analgesic treatment tools can be critical in improving the morbidity associated with the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ASS:

Acute splenic sequestration

IV PCA:

Intravenous patient controlled analgesia

RBC:

Red blood count

SCA:

Sickle cell anemia

SCD:

Sickle cell disease

WBC:

White blood count

References

  1. Olujohungbe A, Howard J. The clinical care of adult patients with sickle cell disease. Br J Hosp Med (Lond). 2008;69(11):616–9.

    Article  Google Scholar 

  2. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325:11–6.

    Article  CAS  PubMed  Google Scholar 

  3. Stuart MJ, Nagel RL. Sickle cell disease. Lancet. 2004;364:1343–60.

    Article  PubMed  Google Scholar 

  4. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–44.

    Article  CAS  PubMed  Google Scholar 

  5. Bernard AW, Venkat A, Lyons MS. Best evidence topic report. Full blood count and reticulocyte count in painful sickle crisis. Emerg Med J. 2006;23(4):302–3.

    Article  PubMed  Google Scholar 

  6. Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008;148(12):932–8.

    Article  PubMed  Google Scholar 

  7. Benjamin LJ. The nature and management of acute painful episode in sickle cell disease. In: Forget BG, Higgs D, Nagel RL, Steinberg MH, editors. Disorders of hemoglobin. Cambridge, UK: Cambridge University Press; 2001. p. 671–710.

    Google Scholar 

  8. Benjamin LJ, Dampier CD, Jacob AK, et al. Guideline for the management of acute and chronic pain in sickle-cell disease. Glenview: APS Clinical Practice Guidelines Series No 1.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leena Mathew M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mathew, L. (2015). Sickle Cell Disease. In: Sackheim, K. (eds) Pain Management and Palliative Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2462-2_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2462-2_26

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2461-5

  • Online ISBN: 978-1-4939-2462-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics